Knowing the order of COVID-19’s symptoms may help patients seek care promptly or decide sooner than later to self-isolate, the scientists say. It also may help doctors rule out other illnesses, according to the study led by doctoral candidate Joseph Larsen and his colleagues with faculty advisors Peter Kuhn and James Hicks at the USC Michelson Center for Convergent Bioscience’s Convergent Science Institute in Cancer.
Recognizing the order of symptoms also could help doctors plan how to treat patients, and perhaps intervene earlier in the disease.
“This order is especially important to know when we have overlapping cycles of illnesses like the flu that coincide with infections of COVID-19,” said Kuhn, a USC professor of medicine, biomedical engineering, and aerospace and mechanical engineering. “Doctors can determine what steps to take to care for the patient, and they may prevent the patient’s condition from worsening.”
“Given that there are now better approaches to treatments for COVID-19, identifying patients earlier could reduce hospitalization time,” said Larsen, the study’s lead author.
Fever and cough are frequently associated with a variety of respiratory illnesses, including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). But the timing and symptoms in the upper and lower gastrointestinal tract set COVID-19 apart.
“The upper GI tract (i.e., nausea/vomiting) seems to be affected before the lower GI tract (i.e., diarrhea) in COVID-19, which is the opposite from MERS and SARS,” the scientists wrote.
The authors predicted the order of symptoms this spring from the rates of symptom incidence of more than 55,000 confirmed coronavirus cases in China, all of which were collected from Feb. 16-Feb. 24, 2020, by the World Health Organization. They also studied a dataset of nearly 1,100 cases collected from Dec. 11, 2019 through Jan. 29, 2020, by the China Medical Treatment Expert Group via the National Health Commission of China.
To compare the order of COVID-19 symptoms to influenza, the researchers examined data from 2,470 cases in North America, Europe and the Southern Hemisphere, which were reported to health authorities from 1994 to 1998.
The scientific findings were published Thursday in the journal Frontiers in Public Health.
“The order of the symptoms matter. Knowing that each illness progresses differently means that doctors can identify sooner whether someone likely has COVID-19, or another illness, which can help them make better treatment decisions,” Larsen, the lead author, said.
###
In addition to Larsen, Kuhn and Hicks, other study co-authors were Margaret R. Martin of Nexus Development PA LLC and John D. Martin at NanoCarrier Co., Ltd., in Chiba, Japan.
The Michelson Center brings together a diverse network of scientists and engineers from USC Dornsife, USC Viterbi School of Engineering and Keck School of Medicine of USC to solve some of the greatest intractable problems of the 21st century — from cancer, to neurological disease, to cardiovascular disease. Established with a generous $50 million gift from retired orthopedic spinal surgeon Gary K. Michelson and his wife, Alya Michelson, the Michelson Center aims to transform and influence the course of scientific discovery and biomedicine for generations to come.
The study was funded by National Cancer Institute (Award Number U54CA143906 and P30CA014089) and the Carol Vassiliadis fellowship. Larsen was supported by the USC Dana and David Dornsife College of Letters, Arts and Sciences, and the Schlegel Family Endowment Fellowship.
Original post https://alertarticles.info